Rankings
▼
Calendar
CRON
Cronos Group Inc.
$983M
Q4 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$30M
+26.7% YoY
Gross Profit
$11M
35.7% margin
Operating Income
-$11M
-37.5% margin
Net Income
$44M
144.3% margin
EPS (Diluted)
$0.11
QoQ Revenue Growth
-11.6%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$55M
Stockholders' Equity
$1.1B
Cash & Equivalents
$859M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30M
$24M
+26.7%
Gross Profit
$11M
$2M
+464.9%
Operating Income
-$11M
-$22M
+47.5%
Net Income
$44M
-$45M
+197.6%
Revenue Segments
Cannabis Flower
$70M
76%
Cannabis Extracts
$21M
23%
Product and Service, Other
$499,000
1%
← FY 2024
All Quarters
Q1 2025 →
CRON Q4 2024 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena